GENZ Related Hot List
-
Blackrock (BLK) to replace Genzyme (GENZ) in S&P 500
-
Genzyme (GENZ) Agrees To Be Acquired by Sanofi-aventis (SNY) for $20.1 Billion
-
Sanofi (SNY) talks said to value Genzyme (GENZ) at $76-$77/share with CVR fee -Bloomberg
-
Genzyme (GENZ) Reports Q3 Miss; Narrows Q4 EPS Outlook
-
Sanofi (SNY) Board said to support Genzyme (GENZ) bid of up to $70/share
-
Sanofi-Aventis "Increasing Likely" to Make Formal Genzyme (GENZ) Offer - WSJ
-
Sanofi-Aventis (SNY) makes informal bid for Genzyme (GENZ) - CNBC Faber
-
Genzyme (GENZ) Reports Q2 Adj-EPS of 18c; Guides Q3, Slashes FY10 EPS Outlook
-
FDA to Take Enforcement Action Related to Genzyme's (GENZ) Allston Plant
-
Genzyme (GENZ) Receives Notice of Icahn Partners' Nomination
-
Genzyme Corp. (GENZ) Posts Q4 adj.-EPS of $0.31, Tops by 2c; Sees Q1, FY10
-
Genzyme (GENZ) Misses Street's Q3 Views; Lowers FY09 Outlook
-
Genzyme (GENZ) Reports In-Line Q2; Cuts Guidance
-
Genzyme (GENZ) Sinks After Interrupting Production at Allston Plant
-
Genzyme (GENZ) Lowers FY09 Adj-EPS Guidance
-
Genzyme (GENZ) Receives Complete Response Letter From FDA For Lumizyme Application; Anticipates Negative Impact To 2009 Earnings
-
Genzyme (GENZ) Reports Q3 Adj-EPS of $1.04, Beats by 4c; Guides FY09 EPS
-
FDA Provides Guidance on Isis (ISIS) and Genzyme's (GENZ) Mipomersen; Isis Down 25%+ on News
-
Genzyme (GENZ) Tops Q1 Estimates, Issues Guidance
-
Genzyme (GENZ) Lowers Guidance After FDA Opinion on Myozyme
-
ISIS Pharma (ISIS) Halted Because Of Genzyme (GENZ) News
-
Genzyme (GENZ) Announces Second Phase 3 Trial of Mozobil Meets Primary Endpoint
-
Genzyme (GENZ) Tops Q2 EPS by 7c; Guides Higher
-
Genzyme (GENZ) to Acquire Bioenvision (BIVN) for $5.60 Per Share
-
Genzyme (GENZ) Terminate Joint Venture With Dyax (DYAX) on DX-88 in HAE
-
Genzyme (GENZ) Retains Separate Medicare Code and Reimbursement Rate for Synvisc
-
Genzyme (GENZ) to Acquire AnorMED Inc. (ANOR) for $13.50 Per Share
-
AnorMED (AOM) Rejects $8.55/Share Offer from Genzyme (GENZ)
-
Genzyme Corp. (GENZ) Misses Q1 EPS by 4c, Guides For Full-Year
-
GENZ Updates Q4, FY05 and Gives FY06 Guidance
-
GENZ Tops Q2 Views; Provides Upbeat Guidance
-
GENZ Buys BCII for $33/share
Back to GENZ Stock Lookup
